On Monday, 16 March 2026, InMode Ltd (NASDAQ:INMD) participated in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. The company outlined its strategic initiatives amidst ...
On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash.
Investing.com -- InMode Ltd. (NASDAQ:INMD) shares rose 6.4% Friday following the company’s announcement of a new share repurchase program authorized by its Board of Directors. The medical technology ...
InMode shares were 6% higher, at $13.48, after the company said its board of directors has authorized a new share repurchase program for up to 10% of its total shares outstanding. The medical ...
YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a ...
March 2026 TIOBE Index stays largely steady, with SQL and R swapping spots, as Paul Jansen explains why the index still ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
This article was published on Feb. 24, 2026, at 10:15 a.m. on the ChosunBiz MoneyMove site. Global aesthetic medical device corporation InMode, listed on the U.S. Nasdaq, has decided to suspend the ...
YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results